A carregar...
Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience
Hepatocellular carcinoma (HCC) is a challenging to treat malignancy with few available systemic therapies. Angiogenesis has been implicated in the pathogenesis of HCC and prior studies have suggested a role for anti‐VEGF therapy. Prior to FDA approval of second‐line therapy for advanced HCC, from 20...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488135/ https://ncbi.nlm.nih.gov/pubmed/30790466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|